About MPM BioImpact
MPM BioImpact is a Healthcare company based in Boston (United States). Investment in biotech companies is facilitated to transform patient outcomes. It operates on a Professional Services and Brokerage / Intermediation model. MPM BioImpact offers products and services including Biotech Investment and Company Building. Its focus areas include Biotechnology and Drug Development.
Company details
Investment in private and public biotech companies is managed by MPM BioImpact to support drug development processes. Focus is placed on transforming scientific breakthroughs into life-saving medicines. Sectors such as oncology, autoimmune diseases, and rare diseases are targeted through portfolio companies like Orna Therapeutics, Aktis Oncology, ElevateBio, and NextPoint Therapeutics. Solutions include funding, strategic support, and expertise in navigating regulatory landscapes to bring innovative therapies to market for patients in need.
- Headquarters Boston, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mpmbioimpact.com
- Social LinkedIn
Products & Services of MPM BioImpact
MPM BioImpact offers a comprehensive portfolio of products and services, including Biotech Investment and Company Building.
Investment in biotech companies is provided for drug development.
Support for building biotech firms is offered to innovators.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as MPM BioImpact (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mpm Bioimpact
Complete news archive for MPM BioImpact
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MPM BioImpact
MPM BioImpact is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Investment in private and public biotech companies is managed by MPM BioImpact to support drug development processes. Focus is placed on transforming scientific breakthroughs into life-saving medicines. Sectors such as oncology, autoimmune diseases, and rare diseases are targeted through portfolio companies like Orna Therapeutics, Aktis Oncology, ElevateBio, and NextPoint Therapeutics. Solutions include funding, strategic support, and expertise in navigating regulatory landscapes to bring innovative therapies to market for patients in need.
MPM BioImpact offers Biotech Investment and Company Building.